Company: CRVO
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001437749-25-013543
Chunk: 56

Company: CervoMed Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 56
---
 Company’s historical results of operations for all periods prior to the Merger and, for all periods following the Merger, the results of operations of the combined company will be included in the Company’s financial statements. Following the completion of the Merger, the business conducted by the Company became primarily the business conducted by EIP. The dollar amounts reported are the net income of the Company as reflected in the Annual Report (or, with respect to net income for the year ended December 31, 2022, which is amount reported in the Company’s Annual Report for the year then-ended filed with the SEC on March 29, 2024) and may not be reflective of the net income of EIP or Diffusion during the applicable periods. |

Relationship of Compensation Actually Paid and Performance Measures

<div align='center'>30

EQUITY COMPENSATION PLAN INFORMATION</div>

The following table provides certain aggregate information with respect to our equity compensation plans in effect as of December 31, 2024.

| Plan category                                                  |     | Number of        
 securities to be 
 issued upon      
 exercise of      
 outstanding      
 options,         
 warrants and     
 rights           |         |     | Weighted-         
 average           
 exercise price of 
 outstanding       
 options,          
 warrants and      
 rights            |       |     | Number of          
 securities         
 remaining          
 available for      
 future issuance    
 under              
 equity             
 compensation       
 plans              
 (excluding         
 securities         
 reflected in first 
 column)            |        |    |
|:---------------------------------------------------------------|:----|:-----------------|--------:|:----|:------------------|------:|:----|:-------------------|-------:|---:|
| Equity compensation plans approved by security holders (1)     |     |                  | 367,932 |     | $                 | 20.85 |     |                    | 23,843 | -2 |
| Equity compensation plans not approved by security holders (3) |     |                  | 236,872 |     | $                 | 17.46 |     |                    |      0 |    |
| Total                                                          |     |                  | 636,804 |     | $                 | 19.52 |     |                    | 23,843 | -2 |

| (1) | Includes securities issued and issuable pursuant to the 2015 Equity Plan but excludes 32,000 shares granted to a non-executive employee on October 15, 2024, the continued holding of which was contingent upon the